Back to top
more

Merck & Co. (MRK)

(Delayed Data from NYSE)

$93.13 USD

93.13
25,247,523

+1.13 (1.23%)

Updated Jun 24, 2022 04:06 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.75%
2Buy18.15%
3Hold9.70%
4Sell5.35%
5Strong Sell2.45%
S&P50010.91%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (157 out of 250)

Industry: Large Cap Pharmaceuticals

Trades from $1

Balance Sheet

Research for MRK

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Merck & Co, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Assets          
Cash & Equivalents 8,096 8,062 10,450 8,864 8,498
Receivables 9,230 7,851 6,778 7,071 6,873
Notes Receivable 0 0 0 0 0
Inventories 5,953 6,310 5,978 5,440 5,096
Other Current Assets 6,987 5,541 4,277 4,500 4,299
Total Current Assets 30,266 27,764 27,483 25,875 24,766
Net Property & Equipment 19,279 17,986 15,053 13,291 12,439
Investments & Advances 370 785 1,469 6,233 12,125
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 44,197 34,842 33,621 29,684 32,467
Deposits & Other Assets 11,582 10,211 6,771 7,554 6,075
Total Assets 105,694 91,588 84,397 82,637 87,872
Liabilities & Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Notes Payable 2,412 6,431 3,610 5,308 3,057
Accounts Payable 4,609 4,594 3,738 3,318 3,102
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 13,859 13,053 12,549 10,151 10,427
Income Taxes Payable 1,224 1,575 736 1,971 708
Other Current Liabilities 1,768 1,674 1,587 1,458 1,320
Total Current Liabilities 23,872 27,327 22,220 22,206 18,614
Mortgages 0 0 0 0 0
Deferred Taxes/Income 3,441 1,015 1,470 1,702 2,219
Convertible Debt 0 0 0 0 0
Long-Term Debt 30,690 25,360 22,736 19,806 21,353
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 9,434 12,482 11,970 12,041 11,117
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 67,437 66,184 58,396 55,755 53,303
Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1,788 1,788 1,788 1,788 1,788
Capital Surplus 44,238 39,588 39,660 38,808 39,902
Retained Earnings 53,696 47,362 46,602 42,579 41,350
Other Equity -4,356 -6,547 -6,099 -5,364 -4,677
Treasury Stock 57,109 56,787 55,950 50,929 43,794
Total Shareholder's Equity 38,257 25,404 26,001 26,882 34,569
Total Liabilities & Shareholder's Equity 105,694 91,588 84,397 82,637 87,872
Total Common Equity 38,257 25,404 26,001 26,882 34,569
Shares Outstanding 2,527.60 2,530.00 2,545.90 2,600.30 2,724.40
Book Value Per Share 15.14 10.04 10.21 10.34 12.69

Fiscal Year End for Merck & Co, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021
Assets          
Cash & Equivalents 8,928 8,096 10,016 8,575 6,981
Receivables 9,828 9,230 8,571 7,843 8,235
Notes Receivable 0 0 0 0 0
Inventories 5,774 5,953 5,603 5,499 6,402
Other Current Assets 6,654 6,987 6,868 6,748 5,291
Total Current Assets 31,184 30,266 31,058 28,665 26,909
Net Property & Equipment 19,747 19,279 18,565 18,064 18,295
Investments & Advances 316 370 435 411 544
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 44,280 44,197 32,246 32,495 34,613
Deposits & Other Assets 11,141 11,582 11,190 11,053 10,486
Total Assets 106,668 105,694 93,494 90,688 90,847
Liabilities & Shareholders Equity 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021
Notes Payable 1,208 2,412 3,534 2,488 7,251
Accounts Payable 3,715 4,609 3,366 3,897 4,034
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 14,051 13,859 14,214 12,888 11,911
Income Taxes Payable 1,571 1,224 954 971 1,490
Other Current Liabilities 1,771 1,768 1,660 1,662 1,675
Total Current Liabilities 22,316 23,872 23,728 21,906 26,361
Mortgages 0 0 0 0 0
Deferred Taxes/Income 3,071 3,441 1,527 1,489 1,204
Convertible Debt 0 0 0 0 0
Long-Term Debt 30,586 30,690 22,907 24,033 24,002
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 9,742 9,469 9,872 12,241
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 65,715 67,437 57,631 57,300 63,808
Shareholders Equity 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021
Preferred Stock 0 0 0 0 0
Common Stock (Par) 1,788 1,788 1,788 1,788 1,788
Capital Surplus 44,275 44,238 44,149 44,039 39,613
Retained Earnings 56,252 53,696 51,691 48,777 48,888
Other Equity -4,299 -4,356 -4,521 -4,534 -6,528
Treasury Stock 57,063 57,109 57,244 56,682 56,722
Total Shareholder's Equity 40,953 38,257 35,863 33,388 27,039
Total Liabilities & Shareholder's Equity 106,668 105,694 93,494 90,688 90,847
Total Common Equity 40,953 38,257 35,863 33,388 27,039
Shares Outstanding 2,527.80 2,527.60 2,531.30 2,532.00 2,530.30
Book Value Per Share 16.20 15.14 14.17 13.19 10.69